ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
新加坡股
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
百济神州
299.94
-5.8000
-1.90%
成交量:
47.30万
成交额:
1.43亿
市值:
355.88亿
市盈率:
-80.99
高:
306.58
开:
302.89
低:
298.46
收:
305.74
数据加载中...
总览
公司
新闻
公告
【医药生物】AI技术落地与产品创新呈现加速态势,建议关注AI医疗相关标的——医药生物行业跨市场周报(20250615)(王明瑞)
光大证券研究
·
06-18
百济神州6月16日成交额为8655.04万美元
市场透视
·
06-17
百济神州:2025年第一季度公司营业收入达80.5亿元,同比增长50.2%
市场资讯
·
06-17
中证港股通科技指数:布局港股科技龙头
广发金融工程研究
·
06-16
自免明星biotech的10年,与中国创新药的一个时代
医药时间
·
06-16
A股重大调整,今日生效!
江西商报
·
06-16
媒体视角 | 硬科技赋能国产创新药 科创板助力生物医药产业自立自强
中邮证券
·
06-16
宝发控股拟750万港元收购Kings Construction & Decoration Company全部股份
华尔街见闻
·
06-16
策略周观点:新消费和AI扩散顺序的相似性
信达证券
·
06-15
百济神州授出15万股购股权、172万股受限股份单位及14万股业绩股份单位
财中社
·
06-15
百济神州:公司拟收购扬子江公司100%股权
蓝鲸财经
·
06-15
医药生物行业跟踪周报:创新药BD推动及优秀临床数据 建议关注石药集团、千红制药等
东吴证券
·
06-15
医药生物行业研究周报:2025年基本医保和商保目录调整工作启动 持续重点推荐创新药
天风证券股份有...
·
06-14
53亿美元!14倍价差!中国创新药,正在重构国际化新规则
21财经网
·
06-13
百济神州(06160)授出购股权、受限制股份单位及业绩股份单位
智通财经
·
06-13
药界周刊(2025.6.7—6.13)
金花股份
·
06-13
AII in 研发的百济神州:“创新药一哥”还差一步!
英才商业
·
06-13
媒体视角 | 5款国家一类新药同日获批 科创板创新药企步入收获期
诚通证券财富管理
·
06-13
这款国产创新药在美国售价约为国内售价的14倍!
制药网
·
06-13
创新药牛市,还能火多久?
乔令投研
·
06-13
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/ONC/news?page=8"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ONC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONC\",,,,,undefined,":{"symbol":"ONC","market":"US","secType":"STK","nameCN":"百济神州","latestPrice":299.94,"timestamp":1753905600000,"preClose":305.74,"halted":0,"volume":473024,"delay":0,"floatShares":75541600,"shares":118650120,"eps":-3.70325,"marketStatus":"盘前交易","change":-5.8,"latestTime":"07-31 04:19:28 EDT","open":302.89,"high":306.58,"low":298.46,"amount":142842075.17312,"amplitude":0.026559,"askPrice":302,"askSize":8,"bidPrice":268.87,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.70325,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753968600000},"marketStatusCode":1,"adr":0,"adrRate":13,"exchange":"NASDAQ","adjPreClose":299.94,"postHourTrading":{"tag":"盘后","latestPrice":299.94,"preClose":299.94,"latestTime":"17:04 EDT","volume":1443,"amount":433016.27,"timestamp":1753909481311},"volumeRatio":1.1823342958493739,"impliedVol":0.4534,"impliedVolPercentile":0.7203},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONC\",,,,,undefined,":{"symbol":"ONC","floatShares":75541600,"roa":"-3.22%","roe":"-11.44%","lyrEps":-6.124009,"volumeRatio":1.1823342958493739,"shares":118650120,"dividePrice":0,"high":306.58,"amplitude":0.026559,"preClose":305.74,"low":298.46,"week52Low":155.75,"pbRate":"10.17","psRate":"8.52","week52High":308.87,"institutionHeld":0,"latestPrice":299.94,"committee":0.851852,"eps":-3.70325,"divideRate":0,"volume":473024,"delay":0,"ttmEps":-3.70325,"open":302.89,"prevYearClose":184.71,"prevWeekClose":291.47,"prevMonthClose":242.07,"prevQuarterClose":242.07,"fiveDayClose":294.83,"twentyDayClose":245.16,"sixtyDayClose":255.77,"earningDate":1756483200000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ONC\",pageSize:20,pageCount:8,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2544991946","title":"【医药生物】AI技术落地与产品创新呈现加速态势,建议关注AI医疗相关标的——医药生物行业跨市场周报(20250615)(王明瑞)","url":"https://stock-news.laohu8.com/highlight/detail?id=2544991946","media":"光大证券研究","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544991946?lang=zh_cn&edition=fundamental","pubTime":"2025-06-18 07:02","pubTimestamp":1750201320,"startTime":"0","endTime":"0","summary":"光大证券研究所不会因关注、收到或阅读本订阅号推送内容而视相关人员为光大证券的客户。预期未来将有更多的中国药企通过AI平台授权参与全球创新,推动产业链向技术驱动转型。AI制药有望成为创新药国际化的重要引擎。如因侵权行为给光大证券造成任何直接或间接的损失,光大证券保留追究一切法律责任的权利。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618075253a70f46ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618075253a70f46ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","IE00BZ08YT58.USD","LU1152091168.USD","LU1226288170.HKD","IE0008368742.USD","LU1008478684.HKD","LU1152091754.HKD","ONC","LU0067412154.USD","LU1226287529.USD","IE0008369823.USD","LU0326950275.SGD","BK1191","LU1951186391.HKD","600079","BK1515","LU0501845795.SGD","BK1521","600276","IE00BZ08YS42.EUR","LU1226287792.SGD","LU0880133367.SGD","IE00B031HY20.USD","09926","SG9999004220.SGD","01093","LU1960683339.HKD","IE00B543WZ88.USD","LU1226287875.USD","IE00B5MMRT66.SGD","LU0140636845.USD","LU1226288253.USD","IE00BZ08YR35.GBP","LU0072913022.USD","LU1807302812.USD","LU1993786604.SGD"],"gpt_icon":1},{"id":"2544934966","title":"百济神州6月16日成交额为8655.04万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544934966","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544934966?lang=zh_cn&edition=fundamental","pubTime":"2025-06-17 12:24","pubTimestamp":1750134259,"startTime":"0","endTime":"0","summary":"美东时间2025年6月16日,百济神州成交额为8655.04万美元,成交额较昨日减少18.48%,当日成交量为32.67万股。百济神州于2025年6月16日跌1.93%,报264.42美元,该股过去5个交易日涨0.24%,年初至今涨43.15%,过去60日涨0.7%。百济神州有自己的团队进行全球临床试验。截至2023年,百济神州的核心药物是百悦泽,这是一种治疗各种血癌的小分子药物,占百济神州收入的50%以上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617122425a70d7981&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617122425a70d7981&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4526","ONC","BK4139"],"gpt_icon":0},{"id":"2544793964","title":"百济神州:2025年第一季度公司营业收入达80.5亿元,同比增长50.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544793964","media":"市场资讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544793964?lang=zh_cn&edition=fundamental","pubTime":"2025-06-17 11:32","pubTimestamp":1750131120,"startTime":"0","endTime":"0","summary":"来源:Gangtise投研\n 百济神州2025年第一季度财报显示,公司营业收入达80.5亿元,同比增长50.2%,主要得益于产品收入的增长。经调整后,公司实现营业利润11.71亿元,净利润8.85亿元。研发投入为34.74亿元,占营业收入的比例为43.16%。公司总资产为421亿元,归属于上市公司股东的所有者权益为252亿元。前十大股东中,安进持股比例为17.55%,为最大股东。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:郝欣煜","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-06-17/doc-infakazn8790286.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688235","06160","ONC"],"gpt_icon":0},{"id":"2543677031","title":"中证港股通科技指数:布局港股科技龙头","url":"https://stock-news.laohu8.com/highlight/detail?id=2543677031","media":"广发金融工程研究","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543677031?lang=zh_cn&edition=fundamental","pubTime":"2025-06-16 20:39","pubTimestamp":1750077591,"startTime":"0","endTime":"0","summary":"摘要中证港股通科技指数:专注港股科技,注重基本面优选。指数从港股通范围内选取50只市值较大、研发投入较高且营收增速较好的科技龙头上市公司作为样本,以反映港股通内科技龙头上市公司的整体表现。2014年底以来,中证港股通科技指数年化收益高于国证港股通科技、恒生科技等其他同类指数。(一)指数编制中证港股通科技指数的编制方案相对独特。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616204524a70c21b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616204524a70c21b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06160","BK0239","688235","159723","603259","02359","ONC"],"gpt_icon":0},{"id":"2543562283","title":"自免明星biotech的10年,与中国创新药的一个时代","url":"https://stock-news.laohu8.com/highlight/detail?id=2543562283","media":"医药时间","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543562283?lang=zh_cn&edition=fundamental","pubTime":"2025-06-16 16:52","pubTimestamp":1750063963,"startTime":"0","endTime":"0","summary":"2021年高点坠落至今,创新药又用了整整4年打了一场翻身仗。一部分诞生于2015年前后的药企,是推动当下中国创新药价值“重估”的主力军。2015年,中国药政改革开启新纪元,创新药迎来春天。在当时,押注自免赛道的biotech可能战略太过前瞻,跑得太快,以至于连时代都跟不上脚步。2021年,泡沫破裂。技术派biotech,差异化突围。这家深耕自免领域10年的biotech,经历周期沉浮,终于来到创新成果加速兑现阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616170544a4abb409&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616170544a4abb409&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688235","BK4526","BK4096","06160","PN","ONC","BK4139"],"gpt_icon":0},{"id":"2543641642","title":"A股重大调整,今日生效!","url":"https://stock-news.laohu8.com/highlight/detail?id=2543641642","media":"江西商报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543641642?lang=zh_cn&edition=fundamental","pubTime":"2025-06-16 11:42","pubTimestamp":1750045378,"startTime":"0","endTime":"0","summary":"A股系列指数调样,今日生效!根据此前消息,6月16日为A股系列指数定期例行调整的生效日。4条沪市指数合计换61只样本此次调样中,4条沪市指数合计更换61只样本。其中,深证成指调整20只样本,创业板指调整8只,深证100指数调整3只。深证成指是A股市场中制造业占比最高的标尺指数之一,本次调整后制造业样本公司权重占73%,211家公司2024年实现收入、盈利双增长。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616114455a70b4064&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616114455a70b4064&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["605499","ONC","601989","BK4526","06160","BK4139","600111"],"gpt_icon":0},{"id":"2543610335","title":"媒体视角 | 硬科技赋能国产创新药 科创板助力生物医药产业自立自强","url":"https://stock-news.laohu8.com/highlight/detail?id=2543610335","media":"中邮证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543610335?lang=zh_cn&edition=fundamental","pubTime":"2025-06-16 09:01","pubTimestamp":1750035718,"startTime":"0","endTime":"0","summary":"一年来,国产创新药的亮眼成绩单,不断擦亮中国生物医药产业的“硬招牌”。出海竞技 加快融入全球产业链及价值链当国产创新药在全球价值链上游占据领先位置,“中国方案”“中国标准”大步迈向国际舞台,科创板创新药企不断取得新的突破。该笔交易一举创下国产创新药出海首付款的最新纪录。近日,国家知识产权局发布第二十五届中国专利奖获奖名单,艾力斯榜上有名。迪哲医药是首批受益者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616090458a4aaf624&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616090458a4aaf624&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688235","06160","01877","BK4139","BK4526","688278","ONC","688180"],"gpt_icon":0},{"id":"2543048643","title":"宝发控股拟750万港元收购Kings Construction & Decoration Company全部股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2543048643","media":"华尔街见闻","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543048643?lang=zh_cn&edition=fundamental","pubTime":"2025-06-16 07:07","pubTimestamp":1750028875,"startTime":"0","endTime":"0","summary":"数据显示,2025年第一季度,中国药企参与的并购与授权交易总值翻倍至369亿美元,占全球总量的半数以上。报告显示,2025年截至6月8日,中国企业对外授权交易首付款已超过25亿美元,总金额超过500亿美元,已达2024年全年水平。2024年,中国有704款原研创新药首次进入临床,数量位居全球第一。GLP-1减重药物市场2024年全球销售额超500亿美金,中国企业积极布局多靶点及口服小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616100729a70b16bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616100729a70b16bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09926","BK4526","BK4588","688235","LU0053666078.USD","06160","BK4585","01276","L","01801","08532","600276","BK4107","ONC","BK4139"],"gpt_icon":0},{"id":"2543961338","title":"策略周观点:新消费和AI扩散顺序的相似性","url":"https://stock-news.laohu8.com/highlight/detail?id=2543961338","media":"信达证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543961338?lang=zh_cn&edition=fundamental","pubTime":"2025-06-15 22:06","pubTimestamp":1749996378,"startTime":"0","endTime":"0","summary":"新消费中有望最后上涨的是创新药,AI中有望最后上涨的是港股互联网。7月开始股市也进入了季报披露期,按照AI的经验,扩散性行情,在季报披露期前后会有些波折。新消费和AI产业逻辑有很大的不同,但如果仔细观察内部细分行业的轮动顺序,能够看到有很大的相似性。AI和新消费交易热度持续扩散。创新药过去1个月是消费中最强的方向,我们认为这与AI行情中港股互联网在春季行情中领涨有很多相似。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250615220624951d74c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250615220624951d74c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09992","ONC","688235","BK4139","BK4585","06181","BK4526","FDN","BK4588","06160","BK4550"],"gpt_icon":0},{"id":"2543166692","title":"百济神州授出15万股购股权、172万股受限股份单位及14万股业绩股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2543166692","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543166692?lang=zh_cn&edition=fundamental","pubTime":"2025-06-15 16:39","pubTimestamp":1749976782,"startTime":"0","endTime":"0","summary":"6月15日,百济神州(688235/06160/BGNE)发布公告,2025年6月10日,公司董事会及薪酬委员会根据2016期权及激励计划的条款,向31名承授人授出可认购合共15万股美国存托股份的购股权,向9012名承授人授出涉及合共172万股美国存托股份的受限制股份单位,向30名承授人授出涉及合共14万股美国存托股份的业绩股份单位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202506153430844674.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1583","LU0588546209.SGD","BK1500","BK4526","LU2328871848.SGD","ONC","BK4139","LU1969619763.USD","BK1161","BK1588","LU0307460666.USD","06160"],"gpt_icon":0},{"id":"2543694437","title":"百济神州:公司拟收购扬子江公司100%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2543694437","media":"蓝鲸财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543694437?lang=zh_cn&edition=fundamental","pubTime":"2025-06-15 15:32","pubTimestamp":1749972730,"startTime":"0","endTime":"0","summary":"蓝鲸新闻6月15日电,百济神州(688235.SH)公告称,公司拟以9037.98万元收购扬子江公司100%股权。此次收购旨在扩大公司业务规模,提升市场竞争力。交易完成后,扬子江公司将成为公司的全资子公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506151534079780540b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506151534079780540b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","06160","ONC","BK4526","688235"],"gpt_icon":0},{"id":"2543769230","title":"医药生物行业跟踪周报:创新药BD推动及优秀临床数据 建议关注石药集团、千红制药等","url":"https://stock-news.laohu8.com/highlight/detail?id=2543769230","media":"东吴证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543769230?lang=zh_cn&edition=fundamental","pubTime":"2025-06-15 00:00","pubTimestamp":1749916800,"startTime":"0","endTime":"0","summary":"R/RAML 存在未被满足临床需求,千红制药全球领先。据医药经济报数据,2024 年全球血液恶性肿瘤治疗药物市场规模达400 亿美元,艾伯维的维奈克拉2024 销售额25.83 亿美元,预计峰值达60 亿美元。FDA 表示,这是HNSCC 领域6 年来的首个新药批准,也是首个获批用于围手术期治疗局部晚期HNSCC 的药物。事件1:石药集团与阿斯利康达成53 亿美金战略合作。利好创新药,建议关注石药集团、信达生物、三生制药、百济神州等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250615163115a4aa1920&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250615163115a4aa1920&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["002550","BK0070","01530","01276","688235","163118","600276","06160","02359","01801","03933","09926","688506","600285","600566","600422","688266","603998","688271","000808.SH","BK0188","BK0239","600535","603259","159992","01093","688192","ONC","600750","BK0077"],"gpt_icon":0},{"id":"2543545666","title":"医药生物行业研究周报:2025年基本医保和商保目录调整工作启动 持续重点推荐创新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2543545666","media":"天风证券股份有...","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543545666?lang=zh_cn&edition=fundamental","pubTime":"2025-06-14 00:00","pubTimestamp":1749830400,"startTime":"0","endTime":"0","summary":"行业动态:根据相关媒体报道,6 月16 日 国家医保局将召开相关行业座谈会,就《2025 年国家基本医疗保险、生育保险和工伤保险药品目录及商业健康保险创新药品目录调整工作方案》征求意见。商业健康保险创新药品目录也在本次方案中,后续重点关注商保目录的遴选原则,价格协商,进院准入,医院使用等支持政策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614173906951c398f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614173906951c398f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159992","LU2488822045.USD","ONC","BK0012","BK0028","BK0188","LU0405327148.USD","BK0183","688235","600276","LU0405327494.USD","000808.SH","LU1064131003.USD","LU1064130708.USD","BK0060","LU2148510915.USD","BK0239","LU2328871848.SGD","LU1969619763.USD","LU1328615791.USD","163118","BK0196"],"gpt_icon":0},{"id":"2543684072","title":"53亿美元!14倍价差!中国创新药,正在重构国际化新规则","url":"https://stock-news.laohu8.com/highlight/detail?id=2543684072","media":"21财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543684072?lang=zh_cn&edition=fundamental","pubTime":"2025-06-13 20:30","pubTimestamp":1749817853,"startTime":"0","endTime":"0","summary":"而从亿帆医药在美国终端定价情况来看,验证了中国创新药出海的高附加值潜力。押注中国创新从此次石药集团与阿斯利康订立的战略研发合作协议金额来看,超53亿美元的交易额在2024年至今的中国生物医药领域中位列前三,这一成就凸显了本土创新平台价值重估的逻辑。这些数据表明,中国创新药企的竞争力正在显著增强。目前,替雷利珠单抗已在全球46个市场获批上市,超90万例患者接受治疗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613203348977e39dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613203348977e39dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ08YT58.USD","LU1152091168.USD","LU1226288170.HKD","IE0008368742.USD","LU1008478684.HKD","LU1152091754.HKD","ONC","LU0067412154.USD","LU1226287529.USD","IE0008369823.USD","LU0326950275.SGD","BK1191","LU1951186391.HKD","BK1515","LU0501845795.SGD","BK1521","IE00BZ08YS42.EUR","LU1226287792.SGD","LU0880133367.SGD","BK1161","IE00B031HY20.USD","SG9999004220.SGD","BK1574","01093","LU1960683339.HKD","IE00B543WZ88.USD","LU1226287875.USD","IE00B5MMRT66.SGD","LU0140636845.USD","LU1226288253.USD","06978","IE00BZ08YR35.GBP","LU0072913022.USD","LU1807302812.USD","LU1993786604.SGD"],"gpt_icon":1},{"id":"2543928681","title":"百济神州(06160)授出购股权、受限制股份单位及业绩股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2543928681","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543928681?lang=zh_cn&edition=fundamental","pubTime":"2025-06-13 19:46","pubTimestamp":1749815168,"startTime":"0","endTime":"0","summary":"智通财经APP讯,百济神州(06160)发布公告,于2025年6月10日,董事会及薪酬委员会根据2016期权及激励计划的条款向31名承授人(包括两名董事)授出可认购合共14.7万股美国存托股份的购股权,向9012名承授人(包括两名董事)授出涉及合共172.01万股美国存托股份的受限制股份单位,并向30名承授人(包括一名董事)授出涉及合共14.14万股美国存托股份的业绩股份单位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1305209.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","ONC","BK4139","BK1588","LU0307460666.USD","LU0588546209.SGD","BK1500","LU2328871848.SGD","BK0239","BK4526","688235","BK1161","06160","LU1969619763.USD"],"gpt_icon":0},{"id":"2543004465","title":"药界周刊(2025.6.7—6.13)","url":"https://stock-news.laohu8.com/highlight/detail?id=2543004465","media":"金花股份","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543004465?lang=zh_cn&edition=fundamental","pubTime":"2025-06-13 17:25","pubTimestamp":1749806724,"startTime":"0","endTime":"0","summary":"2025.6.7-2025.6.13药界周刊药界风云 热点速览#中国生物制药1类新药拟被纳入突破性治疗品种##二代基因测序相关体外诊断试剂管理新规发布#一、行业动态01全国首个中医医疗器械临床评价审评要点发布6月10日,北京市药品监督管理局、天津市药品监督管理局、河北省药品监督管理局共同制定的《第二类中医医疗器械临床评价审评要点》发布,并自发布之日起施行。2024年共销售213万盒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613174543a4a71eee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613174543a4a71eee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688235","BK4526","ONC","BK4139","06160","01177"],"gpt_icon":0},{"id":"2543058945","title":"AII in 研发的百济神州:“创新药一哥”还差一步!","url":"https://stock-news.laohu8.com/highlight/detail?id=2543058945","media":"英才商业","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543058945?lang=zh_cn&edition=fundamental","pubTime":"2025-06-13 16:01","pubTimestamp":1749801677,"startTime":"0","endTime":"0","summary":"百济神州剑走偏锋的“AII in 创新药”模式,距离登顶“创新药一哥”,就差兑现业绩这一步了!!实际上,除了百济神州和恒瑞医药,近两个多月里,A股市场创新药板块的趋势非常强。作为国内医药板块中创新药领域的“独角兽”,百济神州光环众多。百济神州确实很有魄力,从分产品收入来看,公司制作创新药,而且是创新药中最难的抗肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613160350a4a6e7fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613160350a4a6e7fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONC","AII","BK4107","BK4526","688235","600276","BK4139"],"gpt_icon":0},{"id":"2543730275","title":"媒体视角 | 5款国家一类新药同日获批 科创板创新药企步入收获期","url":"https://stock-news.laohu8.com/highlight/detail?id=2543730275","media":"诚通证券财富管理","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543730275?lang=zh_cn&edition=fundamental","pubTime":"2025-06-13 11:03","pubTimestamp":1749783819,"startTime":"0","endTime":"0","summary":"5月29日,国家药监局集中发布11款新药上市批件,科创板创新药企表现亮眼,强势占据其中5席。本次集中获批是科创板创新药企研发管线加速落地的缩影。在新药上市申请受理一端,科创板今年亦是佳音不断。根据公开信息,该笔交易创下国产创新药出海首付款金额的历史新高,达成了国内药企迈向全球市场的又一里程碑,充分体现了国际市场对科创板创新药研发实力的高度认可。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613111055a7068aef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613111055a7068aef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONC","688302","BK4139","688266","688062","BK4526","688235","688278","06160"],"gpt_icon":0},{"id":"2543578367","title":"这款国产创新药在美国售价约为国内售价的14倍!","url":"https://stock-news.laohu8.com/highlight/detail?id=2543578367","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543578367?lang=zh_cn&edition=fundamental","pubTime":"2025-06-13 10:39","pubTimestamp":1749782341,"startTime":"0","endTime":"0","summary":"在我国,该药此前已被纳入国家医保目录,定价为 2388元/支;近日,亿帆医药方面透露,F-627 在美国的最终定价为 4600 美元/支,换算后其在美售价约为国内售价的 14 倍。和黄医药的抗肿瘤新药呋喹替尼,在美国两种规格产品单价分别为 6300 美元和 25200 美元,国内最新医保定价与之相比,差价同样高达数十倍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613104107977d853d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613104107977d853d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCM","BK4531","688180","06160","BK4588","00013","BK4007","BK4585","688235","ONC","01877"],"gpt_icon":0},{"id":"2543524837","title":"创新药牛市,还能火多久?","url":"https://stock-news.laohu8.com/highlight/detail?id=2543524837","media":"乔令投研","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543524837?lang=zh_cn&edition=fundamental","pubTime":"2025-06-13 09:05","pubTimestamp":1749776709,"startTime":"0","endTime":"0","summary":"美国是全球最大的创新药消费市场,美国人口只占了全球的5%,但却支撑了全球3/4的药企利润。恒瑞的港股再上市也为创新药整体估值提供了支撑,因为原本市场预期恒瑞港股上市的估值会低于A股,但意外的是恒瑞港股的市值飙到了3900亿,比A股还贵,其实A股的PS已经超过了12倍。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613090952a706517b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613090952a706517b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0060","LU0405327494.USD","LU2148510915.USD","LU1064130708.USD","BK0188","LU1328615791.USD","159992","ONC","LU1969619763.USD","688235","LU1064131003.USD","BK0183","LU2328871848.SGD","01276","LU0405327148.USD","BK0012","LU2488822045.USD","600276","BK0239","BK0196","06160","688506"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":8,"totalSize":164,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ONC\",params:#limit:5,,,undefined,":[{"date":"2025-08-30","symbol":"ONC","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756540800000,"name":null,"time":"盘前","dateTimestamp":1756526400000,"actualEps":null},{"date":"2025-08-06","symbol":"ONC","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":"2025/06","expectedEps":0.48,"defaultRemindTime":1754467200000,"name":null,"time":"","dateTimestamp":1754452800000,"actualEps":null},{"market":"US","date":"2025-05-07","symbol":"ONC","fiscalQuarterEnding":"2025/03","expectedEps":-0.71,"name":null,"time":"盘前","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"pre","actualEps":1.22},{"market":"US","date":"2025-02-27","symbol":"ONC","fiscalQuarterEnding":"2024/12","expectedEps":-0.88,"name":null,"time":"盘前","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"pre","actualEps":-1.43},{"market":"US","date":"2024-11-12","symbol":"ONC","fiscalQuarterEnding":"2024/09","expectedEps":-0.88,"name":null,"time":"盘前","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-1.15}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ONC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ONC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3182,"buy":0.6364,"hold":0.0455,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6364,"analysts":22,"updateTime":1748318400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ONC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ONC","date":"2025-07-29","current":-89.058804,"percent":0.017123,"low":-89.808695,"twenty":-49.066613,"median":-39.846019,"eighty":-23.213907,"high":-19.234246,"avg":-41.413887,"sd":19.655313,"marketCap":34943646841},"quantilePoints":[{"date":"2024-05-31","current":-19.860847,"twenty":-20.46703,"median":-20.284421,"eighty":-20.042184,"marketCap":15579384952},{"date":"2024-06-07","current":-20.864085,"twenty":-20.930269,"median":-20.558927,"eighty":-20.042184,"marketCap":16366351618},{"date":"2024-06-14","current":-21.694058,"twenty":-21.409839,"median":-20.844737,"eighty":-20.30869,"marketCap":17017405001},{"date":"2024-06-21","current":-20.966373,"twenty":-21.331475,"median":-20.876952,"eighty":-20.46703,"marketCap":16446589390},{"date":"2024-06-28","current":-19.234246,"twenty":-21.331475,"median":-20.825389,"eighty":-19.981739,"marketCap":15087861974},{"date":"2024-07-05","current":-19.83401,"twenty":-21.208618,"median":-20.693442,"eighty":-19.760805,"marketCap":15558333278},{"date":"2024-07-12","current":-20.525989,"twenty":-21.135228,"median":-20.465877,"eighty":-19.641074,"marketCap":16101139655},{"date":"2024-07-19","current":-20.872652,"twenty":-21.016911,"median":-20.525989,"eighty":-19.707798,"marketCap":16373071895},{"date":"2024-07-26","current":-21.924783,"twenty":-21.374239,"median":-20.660298,"eighty":-19.760805,"marketCap":17198391533},{"date":"2024-08-02","current":-22.081827,"twenty":-21.704901,"median":-20.777003,"eighty":-19.839377,"marketCap":17321581561},{"date":"2024-08-09","current":-37.033118,"twenty":-22.009534,"median":-20.868368,"eighty":-19.874904,"marketCap":19394058972},{"date":"2024-08-16","current":-39.443432,"twenty":-22.36867,"median":-20.966373,"eighty":-19.937065,"marketCap":20656328240},{"date":"2024-08-23","current":-39.274234,"twenty":-33.284244,"median":-21.171036,"eighty":-20.00126,"marketCap":20567720015},{"date":"2024-08-30","current":-38.860864,"twenty":-37.912544,"median":-21.248991,"eighty":-20.190606,"marketCap":20351240040},{"date":"2024-09-06","current":-38.812817,"twenty":-38.506257,"median":-21.456019,"eighty":-20.300725,"marketCap":20326078245},{"date":"2024-09-13","current":-40.29759,"twenty":-38.865563,"median":-21.710093,"eighty":-20.355918,"marketCap":21103646159},{"date":"2024-09-20","current":-41.008162,"twenty":-39.353261,"median":-21.954664,"eighty":-20.405766,"marketCap":21475769498},{"date":"2024-09-27","current":-44.343793,"twenty":-39.883427,"median":-22.072098,"eighty":-20.507104,"marketCap":23222622772},{"date":"2024-10-04","current":-49.961787,"twenty":-40.117185,"median":-22.410559,"eighty":-20.525989,"marketCap":26164738255},{"date":"2024-10-11","current":-47.875901,"twenty":-40.317892,"median":-22.855632,"eighty":-20.558927,"marketCap":25072369873},{"date":"2024-10-18","current":-44.402313,"twenty":-41.008162,"median":-37.033118,"eighty":-20.627155,"marketCap":23253269086},{"date":"2024-10-25","current":-43.1532,"twenty":-43.068033,"median":-37.882149,"eighty":-20.693442,"marketCap":22599114920},{"date":"2024-11-01","current":-41.429716,"twenty":-43.148001,"median":-38.271158,"eighty":-20.724275,"marketCap":21696535276},{"date":"2024-11-08","current":-41.685343,"twenty":-43.068033,"median":-38.746669,"eighty":-20.777003,"marketCap":21830405481},{"date":"2024-11-15","current":-24.188369,"twenty":-42.835701,"median":-38.506257,"eighty":-20.825389,"marketCap":20104967290},{"date":"2024-11-22","current":-24.46985,"twenty":-42.494274,"median":-38.062423,"eighty":-20.864085,"marketCap":20240962418},{"date":"2024-11-29","current":-27.613239,"twenty":-42.262623,"median":-37.45966,"eighty":-20.870939,"marketCap":22851200825},{"date":"2024-12-06","current":-26.519964,"twenty":-42.078114,"median":-35.811244,"eighty":-20.886386,"marketCap":21862847938},{"date":"2024-12-13","current":-23.158686,"twenty":-41.984053,"median":-26.690447,"eighty":-20.951062,"marketCap":19077141333},{"date":"2024-12-20","current":-22.876382,"twenty":-41.961072,"median":-26.519964,"eighty":-21.016911,"marketCap":18791641889},{"date":"2024-12-27","current":-23.581122,"twenty":-41.848457,"median":-25.970587,"eighty":-21.108807,"marketCap":19365505627},{"date":"2025-01-03","current":-23.522344,"twenty":-41.738903,"median":-25.015322,"eighty":-21.169159,"marketCap":19262068568},{"date":"2025-01-10","current":-23.039426,"twenty":-41.667895,"median":-24.95255,"eighty":-21.188412,"marketCap":18831625271},{"date":"2025-01-17","current":-27.361812,"twenty":-41.564427,"median":-24.990614,"eighty":-21.226086,"marketCap":22387798297},{"date":"2025-01-24","current":-28.60727,"twenty":-41.429716,"median":-25.817461,"eighty":-21.248991,"marketCap":23666613889},{"date":"2025-01-31","current":-29.006926,"twenty":-41.129457,"median":-26.292693,"eighty":-21.405551,"marketCap":23976726670},{"date":"2025-02-07","current":-29.003485,"twenty":-41.095232,"median":-26.532547,"eighty":-21.456019,"marketCap":23849552911},{"date":"2025-02-14","current":-29.812673,"twenty":-41.008162,"median":-26.754345,"eighty":-21.694058,"marketCap":24634934161},{"date":"2025-02-21","current":-32.964646,"twenty":-40.974605,"median":-27.361812,"eighty":-21.704901,"marketCap":27250381776},{"date":"2025-02-28","current":-45.085214,"twenty":-41.025576,"median":-28.423545,"eighty":-21.711581,"marketCap":29070314911},{"date":"2025-03-07","current":-41.087466,"twenty":-41.189509,"median":-28.729221,"eighty":-21.882341,"marketCap":26492622821},{"date":"2025-03-14","current":-43.209977,"twenty":-41.608729,"median":-28.790129,"eighty":-21.948688,"marketCap":27861188167},{"date":"2025-03-21","current":-42.024306,"twenty":-41.961072,"median":-29.003485,"eighty":-22.009534,"marketCap":27096684166},{"date":"2025-03-28","current":-44.59433,"twenty":-42.028738,"median":-29.052749,"eighty":-22.054545,"marketCap":28753799426},{"date":"2025-04-04","current":-39.846019,"twenty":-42.270172,"median":-29.231496,"eighty":-22.077935,"marketCap":25692155286},{"date":"2025-04-11","current":-38.484462,"twenty":-42.209323,"median":-29.379987,"eighty":-22.177258,"marketCap":24814242135},{"date":"2025-04-17","current":-38.603,"twenty":-42.109763,"median":-29.75631,"eighty":-22.326782,"marketCap":24890673891},{"date":"2025-04-25","current":-40.929408,"twenty":-42.213935,"median":-30.85745,"eighty":-22.4234,"marketCap":26390709308},{"date":"2025-05-02","current":-42.799955,"twenty":-42.322726,"median":-33.161649,"eighty":-22.493794,"marketCap":27596811853},{"date":"2025-05-09","current":-63.824658,"twenty":-42.611855,"median":-33.528671,"eighty":-22.601969,"marketCap":25042625921},{"date":"2025-05-16","current":-62.94985,"twenty":-42.804476,"median":-34.892623,"eighty":-22.71748,"marketCap":24699380815},{"date":"2025-05-23","current":-72.041871,"twenty":-43.150081,"median":-36.84391,"eighty":-22.787779,"marketCap":28266780880},{"date":"2025-05-30","current":-74.527648,"twenty":-43.429182,"median":-37.087829,"eighty":-22.808465,"marketCap":29242115209},{"date":"2025-06-06","current":-77.688492,"twenty":-43.794804,"median":-38.030583,"eighty":-22.84042,"marketCap":30482322820},{"date":"2025-06-13","current":-89.808695,"twenty":-44.177303,"median":-38.271158,"eighty":-22.941372,"marketCap":35237878321},{"date":"2025-06-20","current":-76.439732,"twenty":-44.40516,"median":-38.484462,"eighty":-23.038971,"marketCap":29992352055},{"date":"2025-06-27","current":-76.95683,"twenty":-44.800569,"median":-38.641761,"eighty":-23.063278,"marketCap":30195243589},{"date":"2025-07-03","current":-74.11053,"twenty":-45.138397,"median":-38.836841,"eighty":-23.158686,"marketCap":29078452032},{"date":"2025-07-11","current":-76.495446,"twenty":-45.905367,"median":-39.006759,"eighty":-23.171606,"marketCap":30014212230},{"date":"2025-07-18","current":-87.653233,"twenty":-47.435675,"median":-39.313748,"eighty":-23.176246,"marketCap":34392148550},{"date":"2025-07-25","current":-89.648478,"twenty":-48.541013,"median":-39.640999,"eighty":-23.189441,"marketCap":35175014575},{"date":"2025-07-29","current":-89.058804,"twenty":-49.066613,"median":-39.846019,"eighty":-23.213907,"marketCap":34943646841}],"updateTime":1753949969077}}}